- Home
- ACRV vs SPRU Comparison
ACRV vs SPRU Comparison
Compare ACRV & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- SPRU
- Stock Information
- Founded
- ACRV 2018
- SPRU 2008
- Country
- ACRV United States
- SPRU United States
- Employees
- ACRV N/A
- SPRU N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- SPRU Auto Parts:O.E.M.
- Sector
- ACRV Health Care
- SPRU Consumer Discretionary
- Exchange
- ACRV Nasdaq
- SPRU Nasdaq
- Market Cap
- ACRV 40.4M
- SPRU 34.9M
- IPO Year
- ACRV 2022
- SPRU N/A
- Fundamental
- Price
- ACRV $1.34
- SPRU $1.72
- Analyst Decision
- ACRV Buy
- SPRU
- Analyst Count
- ACRV 7
- SPRU 0
- Target Price
- ACRV $17.60
- SPRU N/A
- AVG Volume (30 Days)
- ACRV 379.9K
- SPRU 99.2K
- Earning Date
- ACRV 08-12-2025
- SPRU 08-13-2025
- Dividend Yield
- ACRV N/A
- SPRU N/A
- EPS Growth
- ACRV N/A
- SPRU N/A
- EPS
- ACRV N/A
- SPRU N/A
- Revenue
- ACRV N/A
- SPRU $87,638,000.00
- Revenue This Year
- ACRV N/A
- SPRU $2.12
- Revenue Next Year
- ACRV N/A
- SPRU N/A
- P/E Ratio
- ACRV N/A
- SPRU N/A
- Revenue Growth
- ACRV N/A
- SPRU 9.48
- 52 Week Low
- ACRV $1.05
- SPRU $1.42
- 52 Week High
- ACRV $10.16
- SPRU $3.60
- Technical
- Relative Strength Index (RSI)
- ACRV 55.88
- SPRU 34.73
- Support Level
- ACRV $1.15
- SPRU $1.50
- Resistance Level
- ACRV $1.38
- SPRU $2.23
- Average True Range (ATR)
- ACRV 0.09
- SPRU 0.16
- MACD
- ACRV 0.02
- SPRU -0.03
- Stochastic Oscillator
- ACRV 83.33
- SPRU 27.40
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.